Viewing StudyNCT03993964

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 1:21 PM
Last Modification Date: 2024-10-26 @ 1:12 PM
Study NCT ID: NCT03993964
Status: UNKNOWN
Last Update Posted: 2019-06-21
First Post: 2019-06-13
Brief Title: Study to Evaluate the Efficacy and Safety of CDK46 Inhibitor SHR6390 Combined With Pyrotinib in the Treatment of HER2-positive Advanced Breast Cancer
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Metastatic Breast Cancer
Keywords: